Status: Not yet recruiting
Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia
This study is an open-label, single-arm clinical trial designed to evaluate the safety and tolerability of QH103 cell infusion in subjects with CD19-positive R/R B-ALL.
Participants needed: 6
Trial details
Phase: Phase 1Age: 14+Biological sex: AllType: InterventionalSponsor: Fujian Medical UniversityUpdated: Mar 24, 2026Locations: 1
Eligibility criteria
Age > 14 years, gender unrestricted; [+11]
No significant hereditary diseases; [+15]